脳脊髄液（CSF）管理の世界市場規模・予測：製品別（CSFシャント、CSF排出）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、RoW）、動向の分析 2012-2022...市場調査レポートについてご紹介

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 CSF Management Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 – 2022
3.3 CSF Management market dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advances driving growth
3.3.1.2 Growing base of aging population more prone to chronic diseases such as Parkinson’s and Alzheimer’s disorders
3.3.1.3 Increasing demand for minimally invasive surgeries
3.3.1.4 Rising cases of stroke and hydrocephalus
3.3.2 Market restraint analysis
3.3.2.1 Rising intricacies of clinical trials
3.3.2.2 Hospital budget constraints & alternative treatment facilities
3.4 Key opportunities prioritized, 2014
3.5 Industry analysis – Porter’s
3.6 CSF management PESTEL Analysis
Chapter 4 CSF Management Product Outlook
4.1 Global CSF Management Revenue Share, by Product, 2014 & 2022
4.1.1 CSF shunts
4.1.1.1 CSF shunts devices market, 2012 – 2022 (USD Million)
4.1.2 CSF Drainage
4.1.2.1 CSF drainage devices market, 2012 – 2022 (USD Million)
Chapter 5 CSF Management Regional Outlook
5.1 CSF management revenue share, by region, 2014 & 2022
5.2 North America
5.2.1 North America CSF management market, 2012 – 2022 (USD Million)
5.3 Europe
5.3.1 Europe CSF management market, 2012 – 2022 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific CSF management market, 2012 – 2022 (USD Million)
5.5 RoW
5.5.1 RoW CSF management market, 2012 – 2022 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 B. Braun Melsungen AG
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Johnson & Johnson Services, Inc
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Integra LifeSciences Corporation
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Spiegelberg GmbH & Co. KG
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Medtronic, Inc.
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 Sophysa
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 BECKERSMITH MEDICAL, Inc
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Phoenix Biomedical Corp.
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 Möller Medical GmbH
6.11.1 Company overview
6.11.2 Financial performance
6.11.3 Product benchmarking
6.11.4 Strategic initiatives
6.12 Elekta AB
6.12.1 Company overview
6.12.2 Financial performance
6.12.3 Product benchmarking
6.12.4 Strategic initiatives